Abstract
The effect of the selective 5-HT3 receptor antagonists, ondansetron and MDL 72222, against various behaviours elicited by naloxone-precipitated morphine withdrawal were examined. Rats made dependent upon morphine by the subcutaneous implantation of a 75 mg pellet, when challenged with naloxone (0.5 mg/kg SC), 3 or 4 days later exhibited a wide range of behaviours including wet dog shakes, paw shakes, salivation and a marked weight loss. Pre-treatment with ondansetron (0.01–1 mg/kg SC) or MDL 72222 (1–3 mg/kg SC) failed to affect the incidence of these responses except weight loss, which was attenuated by both treatments. At doses similar to and below those required to elicit the withdrawal syndrome, naloxone produced a single-trial place aversion in morphine dependent rats. The place aversion produced by naloxone (0.05 mg/kg SC) was antagonized by pre-treatment of ondansetron (0.1–1 mg/kg SC) and MDL 72222 (1 mg/kg SC) prior to conditioning. Chlordiazepoxide (10 mg/kg IP) but not gepirone (3–10 mg/kg SC) was similarly effective. It is concluded that 5-HT3 antagonists may attenuate some but not all behavioural signs associated with morphine withdrawal. Reasons for this apparent selectivity are discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ (1990a) Characterization and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(s)-zacopride in the forebrain of the rat. Neuropharmacology 29:1037–1046
Barnes JM, Barnes NM, Costall B, Naylor IL, Naylor RJ, Rudd JA (1990b) Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem. Naunyn-Schmiedebergs Arch Pharmacol 342:17–21
Barnes JM, Costall B, Coughlan J, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ, Onaivi ES, Tomkins DM, Tyers MB (1990c) The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 35:955–962
Blasig J, Reinhold K, Zieglgansberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology 33:19–38
Childress AR, McLellan AT, Ehrman R, O'Brien CP (1988) Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res Mongr 84:25–43
Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. TIPS 8:383–388
Cicero TJ, Meyer ER (1973) Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence. J Pharmacol Exp Ther 184:404–408
Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of rat and marmoset brain. Br J Pharmacol 92:881–894
Costall B, Jones BJ, Kelly ME, Naylor RJ, Oakley NR, Onaivi ES, Tyers MB (1989a) The effect of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 34:769–778
Costall B, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1989b) Neuroanatomical sites of action of 5-HT3 receptor agonists and antagonists for alteration of aversive behaviour in the mouse. Br J Pharmacol 96:325–332
Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990a) Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav 36:339–344
Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990b) Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 36:97–104
Csanalosi I, Schweizer E, Chase WG, Rickels K (1987) Gepirone in anxiety: a pilot study. J Clin Psychopharmacol 7:31–33
Emmett-Oglesby MW, Mathis DA, Moon RTY, Lal H (1990) Animal models of drug withdrawal symptoms. Psychopharmacology 101:292–309
Gintzler AR (1979) Serotonin participation in gut withdrawal from opiates. J Pharmacol Exp Ther 211:7–12
Goudie AJ, Leathley MJ (1990) Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats. Eur J Pharmacol 185:170–186
Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474:363–368
Higgins GA, Jones BJ, Oakley NR, Tyers MB (1989a) Evidence that the amygdala and not the area postrema is involved in the putative anxiolytic effects of 5-HT3 receptor antagonists. Br J Pharmacol 98:635P
Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB (1989b) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:247–255
Higgins GA, Jones BJ, Oakley NR, Tyers MB (1991) Evidence that the amygdala is involved in the disinhibitory effect of 5-HT3 receptor antagonists. Psychopharmacology (in press)
Johnson SM, Westfall DP, Howard SA, Fleming WW (1978) Sensitivities of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve-vas deferens of the guinea pig after chronic morphine pellet implantation. J Pharmacol Exp Ther 204:54–66
Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR38032F, a 5-HT3 receptor antagonist. Br J Pharmacol 93:985–993
Kehne JH, Cassella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear potentiated startle paradigm. Psychopharmacology 94:8–13
Kilpatrick GJ, Jones BJ, Tyers MB (1989) Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 159:157–164
Koenig JL, Meltzer HY, Gudelsky GA (1988) 5-Hydroxytryptamine1A receptor mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 29:711–715
Laschka E, Teschemacher H, Mehraein P, Herz A (1976) Sites of action of morphine involved in the development of physical dependence in rats. Psychopharmacology 46:141–147
Lecrubier Y (1991) 5-HT3 receptors in anxiety disorders. J Psychopharmacol (in press)
Liebundgut U, Lancranjan I (1987) First results with ICS 205–930 (5-HT3 antagonist) in prevention of chemotherapy-induced emesis. Lancet i:1198
Manning FJ, Jackson MC Jr. (1977) Enduring effects of morphine pellets revealed by conditioned taste aversion. Psychopharmacology 51:279–283
Miner WD, Sanger GJ (1986) Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497–499
Mucha RF (1987) Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 418:214–220
Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology 82:241–247
Mucha RF, Van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91–105
Mucha RF, Gritti MD, Kim C (1986) Aversive properties of opiate withdrawal studied in rats. NIDA Res Monogr 75:567–570
Oakley NR, Jones, BJ, Tyers MB, Costall B, Domeney AM (1988) The effect of GR38032F on alcohol consumption in the marmoset. Br J Pharmacol 95:870P
Pinkus LM, Sarbin NS, Barefoot DS, Gordon JC (1989) Association of [3H]zacopride with 5-HT3 binding sites. Eur J Pharmacol 168:355–362
Pratt GD, Bowery NG, Kilpatrick GJ, Leslie RA, Barnes NM, Naylor RJ, Jones BJ, Nelson DR, Palacios JM, Slater P, Reynolds DJM (1990) Concensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain. TIPS 11:135–137
Preston GC, Broks P, Traub M, Ward C, Poppleton P, Stahl SM (1988) Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology 95:208–215
Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. TINS 9:424–428
Roy-Byrne PP, Uhde TW, Holcomb H, Thomspon K, King AK, Weingartner H (1987) Effects of diazepam on cognitive process in normal subjects. Psychopharmacology 91:30–33
Schultz R, Goldstein A (1973) Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea-pig. Nature 244:168–170
Sellers EM (1978) Clinical pharmacology and therapeutics of benzodiazepines. Can Med Assoc J 118:1533–1538
Sharpe LG, Jaffe JH (1989) Captopril and capsaicin modify opioid withdrawal in the morphine-dependent rat. Pharmacol Biochem Behav 33:899–902
Siegel S (1988) Drug anticipation and the treatment of dependence. NIDA Res Mongr 84:1–24
Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767–773
Waeber C, Pinkus LM, Palacios JM (1990) The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain. Eur J Pharmacol 181:283–287
Wei E, Loh HH, Way EL (1973) Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 184:398–403
Wise RA (1988) The neurobiology of craving: implication for the understanding and treatment of addiction. J Abnorm Psychol 97:118–132
Author information
Authors and Affiliations
Additional information
The views expressed in this manuscript are those of the authors and do not necessarily reflect those of the Addiction Research Foundation.
Rights and permissions
About this article
Cite this article
Higgins, G.A., Nguyen, P., Joharchi, N. et al. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal. Psychopharmacology 105, 322–328 (1991). https://doi.org/10.1007/BF02244425
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244425